Negara: Malaysia
Bahasa: Inggris
Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
ANASTROZOLE
ASTRAZENECA SDN. BHD.
ANASTROZOLE
28Tablet Tablets
AstraZeneca Pharmaceuticals LP
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ ARIMIDEX ® 1MG TABLET _ _ Anastrozole 1mg 1 WHAT IS IN THIS LEAFLET 1. What Arimidex 1mg Tablet is used for 2. How Arimidex 1mg Tablet works 3. Before you use Arimidex 1mg Tablet 4. How to use Arimidex 1mg Tablet 5. While you are using it 6. Side effects 7. Storage and Disposal of Arimidex 1mg Tablet 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of Revision 11. Serial Number WHAT ARIMIDEX 1MG TABLET IS USED FOR Arimidex 1mg Tablet is used to treat breast cancer in post- menopausal women. HOW ARIMIDEX 1MG TABLET WORKS Arimidex 1mg Tablet belongs to a group of medicines called aromatase inhibitors. This means that it interferes with some of the actions of aromatase, an enzyme within the body which effects the level of certain female sex hormones such as oestrogens. BEFORE YOU USE ARIMIDEX 1MG TABLET_ _ - _When you must not use it _ Do not take Arimidex 1mg Tablet • if you are pregnant or breast feeding your baby. • if you are allergic to anastrozole or any of the other ingredients of Arimidex 1mg Tablet listed at the end of this leaflet - _Before you start to use it _ Take special care with Arimidex 1mg Tablet • if you are suffering from any disorder or disease which affects your heart, liver or kidneys. Please inform your doctor. Arimidex 1mg Tablet is not recommended if you are pre- menopausal, and it should not be given to children. _ _ - _Taking other medicines _ Please inform your doctor: • if you take tamoxifen or medicine containing oestrogen (female sex hormone). It may lessen the effect of Arimidex 1mg Tablet. • if you are taking or have recently taken any other medicines, even those not prescribed. Please note that these statements may also apply to medicine used some time ago. HOW TO USE ARIMIDEX 1MG TABLET - _How much to use and when to use _ _it _ • Follow your doctor's instructions about when and how to take your tablets. • The usual dose is one tablet taken daily. • Swallow the tablet whole with a dri Baca dokumen lengkapnya
PACKAGE LEAFLET TEXT Issued to the Medical Profession Only ARIMIDEX ® Trade Mark PHARMACEUTICAL FORM ARIMIDEX is presented as white, biconvex, film-coated tablets containing 1 mg of anastrozole. A logo is impressed on one side and a tablet strength marking on the other side. THERAPEUTIC INDICATION Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. Treatment of advanced breast cancer in post-menopausal women. Efficacy has not been demonstrated in oestrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. DOSAGE AND METHOD OF ADMINISTRATION Adults including the elderly : One 1mg tablet to be taken orally once a day. Children : Not recommended for use in children (see Pharmacodynamic Properties and Pharmacokinetic Properties). Renal impairment : No dose change is recommended in patients with mild or moderate renal impairment. Hepatic impairment : No dose change is recommended in patients with mild hepatic disease. For early disease, the recommended duration of treatment should be 5 years. CONTRAINDICATIONS ARIMIDEX is contraindicated in: - pregnant or lactating women. - patients with severe renal impairment (creatinine clearance less than 20 ml/min). - patients with moderate or severe hepatic disease. - patients with known hypersensitivity to anastrozole or to any of the excipients as referenced in the list of excipients. Oestrogen-containing therapies should not be co-administered with ARIMIDEX as they would negate its pharmacological action. Concurrent tamoxifen therapy (see Interaction With Other Medicinal Products and Other Forms of Interaction). SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE ARIMIDEX is not recommended for use in children or in premenopausal women as safety and efficacy have not been established in this group of patients (see Pharmacodynamic Properties and Pharmacokinetic Properties). The menopause should be defined biochemically in any patient where there is doubt about hormonal status. There are no da Baca dokumen lengkapnya